Funded Health Care Startups in India
Disclosed deal sizes in this India health care slice are dominated by a single outlier: Sensa Core Medical Instrumentation Pvt Ltd.
Disclosed deal sizes in this India health care slice are dominated by a single outlier: Sensa Core Medical Instrumentation Pvt Ltd. raised $72M on 2025-12-22, dwarfing the next-largest disclosed rounds in the $30M–$50M band (e.g., Rubicon Research at $29M on 2025-08-14 and Even at $30M on 2024-10-23), while several other disclosed rounds cluster well below that level (e.g., multiple $1M–$11M rounds). The smallest disclosed amount is $50K (Symbionic on 2025-03-19), highlighting a wide spread between early-stage raises and larger late-preceding rounds.
Geographically, Bengaluru, Karnataka shows up repeatedly (e.g., SuperLiving on 2026-06-25 for $7M; betterhood on 2026-03-16 for $540K; Ultrahuman on 2025-11-20 for $11M; Dozee on 2025-03-25 for $7M; plus others), indicating a city-level concentration alongside other metros like Delhi and Mumbai. Temporally, the 50 most recent entries span 2024-10-16 through 2026-06-29; within the newest window, several rounds land close together in June 2026 (e.g., Mykare Health $1M on 2026-06-29; SuperLiving $7M on 2026-06-25; Immuneel Therapeutics $11M on 2026-06-08; Qube Health is undisclosed on 2026-06-11).
Most recent rounds
50 of 166116 more funded startups
This page shows the 50 most recent rounds (back to Oct 2024). The full 166-company history for this listing is available on a paid plan.
Unlock all 166 companies in this listing — full funding history, investors, and founders.
Related listings
Frequently asked
What’s the largest disclosed round in this India health care list, and how does it compare to the rest of the disclosed amounts?
Sensa Core Medical Instrumentation Pvt Ltd. is the clear size outlier with $72M on 2025-12-22. The next-largest disclosed rounds shown top out below that, such as Even’s $30M (2024-10-23) and Rubicon Research’s $29M (2025-08-14), while many other disclosed deals sit in lower single-digit millions (e.g., Mykare Health $1M on 2026-06-29; TakeMe2Space $3M on 2026-06-11).
Are undisclosed or unspecified round sizes common enough to affect how investors should interpret these numbers?
They appear frequently: Qube Health (2026-06-11), Dent@Home (2026-06-08), Supply6 (2025-12-22), myUpchar (2025-11-17), and several others are labeled undisclosed across the 50 entries. The smallest disclosed amount is $50K (Symbionic on 2025-03-19), so the disclosed distribution is already wide even before accounting for missing figures.
Which cities show up most consistently across recent rounds?
Bengaluru, Karnataka is repeated across multiple dates and deal sizes, including SuperLiving ($7M on 2026-06-25), Ultrahuman ($11M on 2025-11-20), Dozee ($7M on 2025-03-25), and Fibroheal (seed $740K on 2024-12-15). Delhi and Mumbai also recur (e.g., Gut Clinic $990K on 2026-02-24 in New Delhi; Rubicon Research $29M on 2025-08-14 in Mumbai), but Bengaluru appears more repeatedly in the rows shown.
How concentrated are rounds in the most recent months versus spread across the full time window?
The newest date shown is 2026-06-29 (Mykare Health, $1M), and several other June 2026 deals cluster tightly (e.g., SuperLiving $7M on 2026-06-25; Lissun $260K on 2026-06-17; Immuneel Therapeutics $11M on 2026-06-08). Outside that window, the list extends back to 2024-10-16 (Primus, $20M), indicating a multi-year spread rather than a single burst.
Does stage classification look skewed toward certain stages rather than a balanced mix?
The list includes many early-to-mid labels, with prominent examples of Seed/pre-seed activity (e.g., MediElaj pre-seed $100K on 2026-06-01; Humeta pre-seed $2M on 2025-08-08; Pulse seed $4M on 2026-02-25). At the same time, larger disclosed checks appear at later-labeled stages or higher points in time, such as Immuneel Therapeutics Series B at $11M on 2026-06-08 and Mykare Health Series A at $1M on 2026-06-29, showing a stage mix rather than one dominant single stage.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.